Optimistic Buy Rating for Tenaya Therapeutics Based on Promising Gene Therapy Pipeline and Upcoming Clinical Milestones
Tenaya Therapeutics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)
Buy Rating Affirmed for Tenaya Therapeutics: A Combination of Solid Financials and Promising Clinical Pipeline
Tenaya Therapeutics Analyst Ratings
Canaccord Genuity Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $18
Tenaya Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Tenaya Therapeutics, Maintains $18 Price Target
Analysts' Top Healthcare Picks: Inventiva (IVA), Tenaya Therapeutics (TNYA)
Buy Rating Justified by Tenaya Therapeutics' Strong Financials and Promising Cardiovascular Pipeline Progress
TD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Dexcom (DXCM) and Tenaya Therapeutics (TNYA)
Leerink Partners Initiates Coverage On Tenaya Therapeutics With Outperform Rating, Announces Price Target of $7
Tenaya Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Jazz Pharmaceuticals (JAZZ) and Tenaya Therapeutics (TNYA)
Tenaya Therapeutics (TNYA) Receives a New Rating From Piper Sandler
Strong Financial Performance and Cardiovascular Therapy Developments Support Buy Rating for Tenaya Therapeutics
Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Apellis Pharmaceuticals (APLS)
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Exelixis (EXEL) and Tenaya Therapeutics (TNYA)
Tenaya Therapeutics' Promising FDA Clearance for AAV9 Gene Therapy Boosts Confidence: A Buy Rating Analysis
No Data